HOWTIAN is proud to announce that its High-Purity D-Chiro-Inositol (DCI) has been awarded the Gold Winner of the Ingredient Innovation Award at the 2026 Natural Ingredients Awards, presented during the CPHI China Celebration Awards & Networking Event in Shanghai. The award recognizes breakthrough innovations in natural ingredients that demonstrate exceptional technological advancement, commercial potential, and industry impact.
The Natural Ingredients Awards honor companies that are advancing the future of natural ingredients through novel discovery, sustainable sourcing, and innovative manufacturing technologies. HOWTIAN’s award-winning D-Chiro-Inositol was recognized for overcoming longstanding production challenges that have historically limited the ingredient’s scalability, purity, and environmental sustainability.
Advancing the Future of D-Chiro-Inositol Production
D-Chiro-Inositol is a valuable functional ingredient widely used in dietary supplements and women’s health formulations, particularly for metabolic and hormonal health applications. However, conventional manufacturing methods have faced significant limitations. Traditional chemical synthesis relies on large volumes of organic solvents and generates substantial waste, while natural extraction methods suffer from limited raw material availability and low production yields.
To address these challenges, HOWTIAN developed a proprietary high-efficiency enzymatic biosynthesis platform that establishes a new benchmark for D-Chiro-Inositol production. The company’s R&D team successfully overcame two critical industry bottlenecks:
- Increasing substrate tolerance through directed enzyme evolution, enabling more than a 30% improvement in substrate endurance and tripling single-batch production output
- Developing highly thermostable enzymes capable of maintaining over 95% activity at 50°C, allowing efficient industrial-scale production while reducing energy consumption and improving process efficiency
These innovations have enabled HOWTIAN to deliver D-Chiro-Inositol with:
- Consistent purity of ≥ 99.0% as verified by HPLC testing
- High conversion efficiency with minimal impurity formation
- Exceptional batch-to-batch consistency for reliable formulation performance
Recognition for Innovation at Scale
Receiving the Ingredient Innovation Award underscores HOWTIAN’s commitment to combining scientific innovation with sustainable manufacturing practices. The company’s enzymatic production technology not only improves product quality but also reduces environmental impact while supporting large-scale commercial production.
“This award validates our belief that true ingredient innovation begins at the source,” said a HOWTIAN representative. “By rethinking how D-Chiro-Inositol is produced, we have created a solution that delivers higher purity, greater consistency, and a more sustainable manufacturing pathway for our customers worldwide.”
Showcasing Innovation at CPHI China
As one of the pharmaceutical and natural ingredients industry’s premier events, CPHI China brings together more than 110,000 industry professionals and over 3,600 exhibitors from around the world. The Natural Supply Zone serves as a leading platform for ingredient innovation across nutraceutical, functional food, beverage, and personal care markets.
The recognition of HOWTIAN’s High-Purity D-Chiro-Inositol among the industry’s top ingredient innovations reinforces the company’s position as a global leader in advanced inositol manufacturing and functional ingredient development.